henhaobio
Sign in

Communications BiologyImmunologyPeer-reviewed journal article

Unveiling inverted D genes and D-D fusions in human antibody repertoires unlocks novel antibody diversity

Ponraj PrabakaraniD, Abhinav GuptaiD, Sambasiva P. RaoiD, Deepak K. RajpaliD, Maria WendtiD, Yu QiuiD, Partha Sarathi ChowdhuryiD

PDFDOIPreprint
Citations
3
FWCI
0.98
Field percentile
top 30%

Abstract

Antibodies, fundamental to immune defense, derive their diversity primarily from the intricate rearrangement of variable (V), diversity (D), and joining (J) gene segments. Traditionally, D genes in the forward (5-3) direction contribute to this diversity by rearranging with V and J segments. However, the existence and significance of inverted D genes (InvDs), which are D genes oriented in the inverted (3-5) direction, were previously obscured by limitations in data and detection methods. Here, we carried out a comprehensive analysis of a large-scale public next-generation sequencing (NGS) dataset encompassing antibody repertoires from 13 healthy donors using a novel immunoinformatics workflow. Our analysis, for the first time, uncovers the existence of all 25 unique InvDs across all three reading frames within human antibody repertoires, including both naive and memory B cells. This finding challenges previous assumptions, revealing the extensive presence of InvDs and identifying a broad spectrum of D-D fusions, especially those involving InvDs. Notably, InvDs enrich for unique amino acids such as histidine, proline, and lysine, not commonly found in forward D genes, and exhibit reduced use of certain negatively charged and bulky amino acids, including aspartate, tryptophan, and methionine. The unique amino acid profile of InvDs discloses new diversity and functionality in the human antibody repertoire, evidenced by over two dozen documented antibodies featuring InvDs, targeting a wide array of antigens. By opening exciting avenues for immunogenetics research, including new chromatin compaction models, innovative antibody libraries, and advancements in antibody engineering, these findings hold promise for the development of novel therapeutics and vaccines.

Reproducibility ledger

Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.

Sign in to file a reproducibility report.

Similarity Map
SelectedSame fieldCross-field
THISRodriguez '23Engelbrecht '24Funck '18Branson '25Navas '22Sankar '19
48% semantic matchGenomics
Oscar L. Rodriguez, Yana Safonova, Catherine A. Silver+10 more·Nature Communications·Jul 21, 2023· 126 citations